GGrantIndex
Sort

46,585 grants matching heart failure

PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)

$10,663,839
Karen P Alexander · Duke University · U19 · FY2019 · AG

PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)

$10,487,354
Karen P Alexander · Duke University · U19 · FY2025 · AG

ECHODAC (Environmental Influences on Child Health Outcomes Data Analysis Center)

$10,131,550
Lisa P Jacobson · Johns Hopkins University · U24 · FY2017 · OD

HEART FAILURE WITH PRESERVED EJECTION FRACTION: MECHANISMS AND NOVEL THERAPEUTICS

$10,000,000
Cedars-Sinai Medical Center · · FY2016 · Department of the Army

Individualizing Therapy for Kidney and Heart Transplant Recipients

$9,955,156
Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · AI

Variations in Care: Comparing Heart Failure Care Transition Intervention Effects

$9,898,332
Michael K Ong · University Of California Los Angeles · R01 · FY2010 · HS

NEW ENGLAND REGIONAL PRIMATE RESEARCH CENTER

$9,689,353
Harvard University (Medical School) · P51 · FY2002 · RR

Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet)

$9,549,659
David T Mauger · Pennsylvania State Univ Hershey Med Ctr · U10 · FY2015 · HL

Advancing the Science of Palliative Care Research Across the Lifespan (ASCENT) Consortium

$9,464,050
Jean S Kutner · University Of Colorado Denver · U54 · FY2025 · AG

ASPirin in Reducing Events in the Elderly

$9,375,981
Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2010 · AG

Early EMS and ED Use of GIK for ACS: The IMMEDIATE Trial

$9,273,477
Harry P Selker · Tufts Medical Center · U01 · FY2006 · HL

ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES FOLLOW-ON (ACCORDION) STUDY- C

$9,065,440
Robert Byington · Wake Forest University Health Sciences · N01 · FY2014 · HL

ASPirin in Reducing Events in the Elderly

$8,983,665
Anne M Murray · Hennepin Healthcare Research Institute · U01 · FY2016 · AG

Systolic Blood Pressure Intervention Trial (SPRINT)

$8,875,483
National Heart, Lung, And Blood Institute · Y01 · FY2010 · HL

Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet)

$8,764,803
David T Mauger · Pennsylvania State Univ Hershey Med Ctr · U10 · FY2012 · HL

NEW ENGLAND REGIONAL PRIMATE RESEARCH CENTER

$8,742,353
Harvard University (Medical School) · P51 · FY2001 · RR

Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis

$8,624,024
Brian Lim Hoh · University Of Florida · U01 · FY2021 · NS

ASPirin in Reducing Events in the Elderly

$8,542,640
Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2013 · AG

BIOMEDICAL (BASIC)

$8,515,032
Alfed Cheung · University Of Utah · N01 · FY2010 · HL

BIOMEDICAL (BASIC)

$8,511,177
David C Goff · Wake Forest University Health Sciences · N01 · FY2010 · HL

ASPirin in Reducing Events in the Elderly

$8,485,338
Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2015 · AG

ASPirin in Reducing Events in the Elderly

$8,233,724
Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2014 · AG

NEW ENGLAND REGIONAL PRIMATE RESEARCH CENTER

$8,220,317
Harvard University (Medical School) · P51 · FY2000 · RR

Warfarin vs. Aspirin in Reduced Ejection Fraction (WARCEF)

$8,158,474
Shunichi Homma · Columbia University Health Sciences · U01 · FY2009 · NS

Early EMS and ED Use of GIK for ACS: The IMMEDIATE Trial

$8,111,828
Tufts Medical Center · U01 · FY2005 · HL